Altos Labs focuses on cellular rejuvenation programming to restore cell health and resilience, to reverse disease to transform medicine.
Altos Labs has raised $3.0B in total funding. The most recent round was Series A. The last funding was announced in September 2021.
Altos Labs's investors include ARCH Venture Partners, 8VC, Jeff Bezos, Altitude Life Science Ventures, Breakthrough Prize.
Altos Labs is headquartered in San Francisco, United States.
Altos Labs focuses on cellular rejuvenation programming to restore cell health and resilience, to reverse disease to transform medicine.
Altos Labs is at the Series A stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Altos Labs — Funding & Investors." VCBacked, September 6, 2021, https://www.vcbacked.co/company/altos-labs. Accessed October 17, 2026.
VCBacked. (2021). Altos Labs — Funding & Investors. Retrieved October 17, 2026, from https://www.vcbacked.co/company/altos-labs
{{cite web |title=Altos Labs — Funding & Investors |url=https://www.vcbacked.co/company/altos-labs |website=VCBacked |access-date=October 17, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated